02
Jul
Ex-Pharmacyclics CEO Richard Miller is looking for a second act in biotech with his startup Corvus Pharmaceuticals.
Source: Ex-Pharmacyclics team raises $33.5M for checkpoint drug
Ex-Pharmacyclics CEO Richard Miller is looking for a second act in biotech with his startup Corvus Pharmaceuticals.
Source: Ex-Pharmacyclics team raises $33.5M for checkpoint drug